Advent Pharma Ltd. (DSE:ADVENT)
Bangladesh · Delayed Price · Currency is BDT 14.40
+0.20 (1.41%)
At close: Nov 12, 2026
Advent Pharma Cash Flow Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Net Income | 38.9 | 66.87 | 83.99 | 98.64 | 97.53 |
Depreciation & Amortization | 60.34 | 63.05 | 66.51 | 59.18 | 42.27 |
Loss (Gain) From Sale of Assets | -0.27 | - | 29.61 | 0.02 | - |
Other Operating Activities | 23.98 | 28.53 | 29.68 | 38.47 | 38.36 |
Change in Accounts Receivable | -90.78 | -45.71 | -16.32 | -10.32 | -2.15 |
Change in Inventory | -21.23 | 1.07 | 12.51 | 0.78 | -5.12 |
Change in Accounts Payable | -0.18 | 0.44 | -10.96 | 10.83 | 1.08 |
Change in Other Net Operating Assets | 3.62 | 0.49 | -19.89 | 7.7 | 7.6 |
Operating Cash Flow | 14.38 | 114.74 | 175.13 | 205.3 | 179.57 |
Operating Cash Flow Growth | -87.47% | -34.48% | -14.69% | 14.33% | -0.45% |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Capital Expenditures | -12.22 | -94.18 | -162.06 | -202.73 | -191.13 |
Sale of Property, Plant & Equipment | 1.08 | - | 2.7 | 0.68 | - |
Investment in Securities | - | - | - | - | 40 |
Investing Cash Flow | -11.14 | -94.18 | -159.36 | -202.06 | -151.13 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Short-Term Debt Issued | 1.14 | - | 5.01 | 11.72 | 6.44 |
Total Debt Issued | 1.14 | - | 5.01 | 11.72 | 6.44 |
Short-Term Debt Repaid | - | -1.33 | - | - | - |
Long-Term Debt Repaid | -0.53 | -0.64 | -0.59 | -4.04 | -4.2 |
Lease Payments | -0.53 | -0.64 | -0.59 | -0.46 | -0.65 |
Total Debt Repaid | -0.53 | -1.97 | -0.59 | -4.04 | -4.2 |
Net Debt Issued (Repaid) | 0.62 | -1.97 | 4.42 | 7.68 | 2.25 |
Common Dividends Paid | -1.62 | -14.75 | -8.2 | -8.81 | -22.22 |
Other Financing Activities | -3.57 | -6.04 | -9.1 | -5.35 | -6.84 |
Financing Cash Flow | -4.56 | -22.76 | -12.88 | -6.48 | -26.82 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Miscellaneous Cash Flow Adjustments | - | -0 | 0 | - | - |
Net Cash Flow | -1.32 | -2.2 | 2.89 | -3.24 | 1.63 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | 2.16 | 20.56 | 13.08 | 2.56 | -11.56 |
Free Cash Flow Growth | -89.50% | 57.25% | 409.89% | - | - |
Free Cash Flow Margin | 0.54% | 4.11% | 2.29% | 0.46% | -2.18% |
Free Cash Flow Per Share | 0.02 | 0.22 | 0.14 | 0.03 | -0.12 |
Levered Free Cash Flow | -178.55 | -20.56 | -36.41 | -44.03 | -68.27 |
Unlevered Free Cash Flow | -171.21 | -14.84 | -31.35 | -39.89 | -65.7 |
Free Cash Flow After Leases | 1.64 | 19.93 | 12.49 | 2.11 | -12.21 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash Interest Paid | - | 6.04 | 9.1 | 5.35 | 6.83 |
Cash Income Tax Paid | - | 0.24 | 2.86 | 3.08 | 2.36 |
Change in Working Capital | -108.57 | -43.71 | -34.66 | 8.99 | 1.41 |